These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34661958)

  • 1. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
    Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
    ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
    Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
    Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
    Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
    ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
    Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
    Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
    Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes After En Bloc Iliac Vessel Excision and Reconstruction During Pelvic Exenteration.
    Brown KG; Koh CE; Solomon MJ; Qasabian R; Robinson D; Dubenec S
    Dis Colon Rectum; 2015 Sep; 58(9):850-6. PubMed ID: 26252846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observational study on perioperative outcomes of pelvic exenteration].
    Yuan H; Yao B; Li JT; Zhu WL; Ren DL; Wang H; Ma TH; Chen SQ; Wu JJ; Tao YR; Ye L; Wang ZY; Qu H; Ma B; Zhong WW; Wang DJ; Qiu JG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):260-267. PubMed ID: 36925126
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
    Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
    Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
    Platt E; Dovell G; Smolarek S
    Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
    Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis.
    Peacock O; Smith N; Waters PS; Cheung F; McCormick JJ; Warrier SK; Wagner T; Heriot AG
    Colorectal Dis; 2020 Jul; 22(7):818-823. PubMed ID: 31961476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
    Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration: a review of current issues/controversies.
    Shine RJ; Glyn T; Frizelle F
    ANZ J Surg; 2022 Nov; 92(11):2822-2828. PubMed ID: 35490337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
    Xin KY; Ng DW; Tan GH; Teo MC
    J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
    Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
    Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.
    Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C
    Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.